Next Article in Journal
Correction: Colomba et al. Haemodynamic Forces: Emerging Markers of Ventricular Remodelling in Multiple Myeloma Cardiovascular Baseline Risk Assessment. Cancers 2024, 16, 3081
Previous Article in Journal
Prealbumin Prognostic Score: A Novel Prognostic Indicator After Radical Gastrectomy in Patients with Gastric Cancer
Previous Article in Special Issue
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 16
Issue 23
10.3390/cancers16233890
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Cancers 2020, 12(1), 167.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Montalesi et al. Divergent Effects of Daidzein and Its Metabolites on Estrogen-Induced Survival of Breast Cancer Cells. Cancers 2020, 12, 167

by
Emiliano Montalesi
,
Manuela Cipolletti
,
Patrizio Cracco
,
Marco Fiocchetti
and
Maria Marino
*
Department of Science, University Roma Tre, Viale Guglielmo Marconi 446, I-00146 Roma, Italy
*
Author to whom correspondence should be addressed.
Cancers 2024, 16(23), 3890; https://doi.org/10.3390/cancers16233890
Submission received: 6 November 2024 / Accepted: 7 November 2024 / Published: 21 November 2024
(This article belongs to the Special Issue Role of Natural Bioactive Compounds in the Rise and Fall of Cancers)
Browse Figure
Versions Notes
In the original publication [1], there was a mistake in Figure 4a as published. During figure preparation, we mistakenly included the same line twice (total AKT) in Figure 4a instead of the tubulin present in the original figures. The corrected Figure 4a appears below. In addition, the email of the author Patrizio Cracco has also been changed. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Montalesi, E.; Cipolletti, M.; Cracco, P.; Fiocchetti, M.; Marino, M. Divergent Effects of Daidzein and Its Metabolites on Estrogen-Induced Survival of Breast Cancer Cells. Cancers 2020, 12, 167. [Google Scholar] [CrossRef] [PubMed]
Cancers 16 03890 g004
Figure 4. Daidzein, daidzein-4′-sulfate and equol action mechanism. The phosphorylation of the Ser473 residue of AKT (pAKT) (a,b) and Thr180/Tyr182 residues on P-38 (c,d) was determined by western blot analysis in MCF-7 cells exposed for 1 h (a,c) and 24 h (b,d) to either vehicle (DMSO:PBS 1:1) or E2 (10 nM) in presence or absence of D, D4S and Eq (1 μM). The nitrocellulose was stripped and then probed with anti-AKT or anti-p38 antibodies. In the panels, the PAKT/AKT (a,b) and Pp38/p38 (c,d) ratios are represented. These ratios are calculated with respect to tubulin obtained by densitometric analyses of three different experiments (mean ± SD). p < 0.001 was determined by Student t-test with respect to vehicle (*) or Endox-untreated (°) samples. AKT: protein kinase B; E2: estradiol; Endox: endoxifen; ERα: estrogen receptor α; NGB: neuroglobin; p38: p38 mitogen-activated protein kinase; D: daidzein; D4S: daidzein-4′-sulfate; Eq: equol.
Figure 4. Daidzein, daidzein-4′-sulfate and equol action mechanism. The phosphorylation of the Ser473 residue of AKT (pAKT) (a,b) and Thr180/Tyr182 residues on P-38 (c,d) was determined by western blot analysis in MCF-7 cells exposed for 1 h (a,c) and 24 h (b,d) to either vehicle (DMSO:PBS 1:1) or E2 (10 nM) in presence or absence of D, D4S and Eq (1 μM). The nitrocellulose was stripped and then probed with anti-AKT or anti-p38 antibodies. In the panels, the PAKT/AKT (a,b) and Pp38/p38 (c,d) ratios are represented. These ratios are calculated with respect to tubulin obtained by densitometric analyses of three different experiments (mean ± SD). p < 0.001 was determined by Student t-test with respect to vehicle (*) or Endox-untreated (°) samples. AKT: protein kinase B; E2: estradiol; Endox: endoxifen; ERα: estrogen receptor α; NGB: neuroglobin; p38: p38 mitogen-activated protein kinase; D: daidzein; D4S: daidzein-4′-sulfate; Eq: equol.
Cancers 16 03890 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Montalesi, E.; Cipolletti, M.; Cracco, P.; Fiocchetti, M.; Marino, M. Correction: Montalesi et al. Divergent Effects of Daidzein and Its Metabolites on Estrogen-Induced Survival of Breast Cancer Cells. Cancers 2020, 12, 167. Cancers 2024, 16, 3890. https://doi.org/10.3390/cancers16233890

AMA Style

Montalesi E, Cipolletti M, Cracco P, Fiocchetti M, Marino M. Correction: Montalesi et al. Divergent Effects of Daidzein and Its Metabolites on Estrogen-Induced Survival of Breast Cancer Cells. Cancers 2020, 12, 167. Cancers. 2024; 16(23):3890. https://doi.org/10.3390/cancers16233890

Chicago/Turabian Style

Montalesi, Emiliano, Manuela Cipolletti, Patrizio Cracco, Marco Fiocchetti, and Maria Marino. 2024. "Correction: Montalesi et al. Divergent Effects of Daidzein and Its Metabolites on Estrogen-Induced Survival of Breast Cancer Cells. Cancers 2020, 12, 167" Cancers 16, no. 23: 3890. https://doi.org/10.3390/cancers16233890

APA Style

Montalesi, E., Cipolletti, M., Cracco, P., Fiocchetti, M., & Marino, M. (2024). Correction: Montalesi et al. Divergent Effects of Daidzein and Its Metabolites on Estrogen-Induced Survival of Breast Cancer Cells. Cancers 2020, 12, 167. Cancers, 16(23), 3890. https://doi.org/10.3390/cancers16233890

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop